Postes actifs de Scott Bratman
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Adela, Inc.
 Adela, Inc. Finance/Rental/LeasingFinance Adela, Inc. is a company that is developing technology to accelerate the diagnosis and improve the management of cancer through blood tests for minimal residual disease (MRD) monitoring and multi-cancer early detection (MCED). The company is based in Branford, CT. The company's genome-wide methylome enrichment platform captures extensive, biologically-relevant genomic information to maximize test performance and improve treatment decisions. Adela's approach to MRD testing is tissue agnostic, eliminating the burden of acquiring a tumor sample. The CEO of the company is Scott Bratman. | Corporate Officer/Principal | - | - |
| Directeur/Membre du Conseil | - | - | |
| Directeur Général | - | 25/09/2023 | |
| President | - | - |
Historique de carrière de Scott Bratman
Statistiques
Internationale
| Etats-Unis | 2 |
Opérationnelle
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Adela, Inc.
Adela, Inc. Finance/Rental/LeasingFinance Adela, Inc. is a company that is developing technology to accelerate the diagnosis and improve the management of cancer through blood tests for minimal residual disease (MRD) monitoring and multi-cancer early detection (MCED). The company is based in Branford, CT. The company's genome-wide methylome enrichment platform captures extensive, biologically-relevant genomic information to maximize test performance and improve treatment decisions. Adela's approach to MRD testing is tissue agnostic, eliminating the burden of acquiring a tumor sample. The CEO of the company is Scott Bratman. | Finance |
- Bourse
- Insiders
- Scott Bratman
- Expérience
